AriBio - Crunchbase Company Profile & Funding

Q: Where is AriBio's headquarters?

AriBio is located in Seongnam, Kyonggi-do, South Korea.

Q: Who invested in AriBio?

AriBio has 4 investors including Solux And Milestone.

Q: When was the last funding round for AriBio?

AriBio closed its last funding round on obfuscated from a Corporate Round round.

Overview

AriBio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About AriBio

CB Rank

14186

AriBio is a biotechnology research company that develops novel therapeutics for the treatment of neurodegenerative and infectious diseases.

Founded

obfuscation

Private

Corporate Round

Seongnam, Kyonggi-do, South Korea

51-100

www.aribio.com/

Artificial Intelligence (AI)

Biotechnology

Medical

Funding Rounds

Corporate Round

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Cyrus N. Gill: Associate Director of Clinical Operations / Clinical Consultant
Jai Jun Choung: CEO and Founder

Details

Legal Name

AriBio Co., Ltd

Also Known As

아리바이오

Operating Status

Active

Company Type

For Profit

About the Company

AriBio is a biotechnology firm dedicated to developing therapeutic solutions for neurodegenerative disorders. At AriBio, polypharmacology is strengthened by the capabilities of advanced AI technologies. Utilizing the ARIDD™ platform, the company explores extensive molecular databases, forecasting interactions that encompass various targets and

mechanisms. By harnessing AI, AriBio strives to enhance drug efficacy and broaden potential therapeutic applications. ARIDD™ serves as a drug development platform that enhances the discovery and creation of polypharmacological medications.

Phone Number

+82-02-2637-0009

Predictions & Insights

Growth Insight

See this Growth Insight

AriBio is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

AR1001

An oral drug designed for the treatment of Alzheimer’s disease, demonstrating neuroprotective effects and the ability to slow disease progression through various cognitive and functional assessments.

ARIDD™ platform

A technology platform that integrates AI for the development of drugs targeting neurodegenerative diseases.

Research & Development

AriBio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round
obfuscated obfuscation	Corporate Round - AriBio	1	obfuscated obfuscation	Solux	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Solux	Yes	Corporate Round - AriBio	—
Solux	Yes	Corporate Round - AriBio	—
Solux	Yes	Corporate Round - AriBio	—
Solux	Yes	Corporate Round - AriBio	—
Solux	Yes	Corporate Round - AriBio	—